FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894633078> ?p ?o ?g. }

• W2894633078 endingPage "e27" @default.
• W2894633078 startingPage "e19" @default.
• W2894633078 abstract "BackgroundIn 2007, Australia was one of the first countries to introduce a national human papillomavirus (HPV) vaccination programme, and it has since achieved high vaccination coverage across both sexes. In December, 2017, organised cervical screening in Australia transitioned from cytology-based screening every 2 years for women aged from 18–20 years to 69 years, to primary HPV testing every 5 years for women aged 25–69 years and exit testing for women aged 70–74 years. We aimed to identify the earliest years in which the annual age-standardised incidence of cervical cancer in Australia (which is currently seven cases per 100 000 women) could decrease below two annual thresholds that could be considered to be potential elimination thresholds: a rare cancer threshold (six new cases per 100 000 women) or a lower threshold (four new cases per 100 000 women), since Australia is likely to be one of the first countries to reach these benchmarks.MethodsIn this modelling study, we used Policy1-Cervix—an extensively validated dynamic model of HPV vaccination, natural history, and cervical screening—to estimate the age-standardised incidence of cervical cancer in Australia from 2015 to 2100. We incorporated age-specific coverage of the Australian National HPV Vaccination Program in girls, including the catch-up programme, and the inclusion of boys into the vaccine programme from 2013, and a change from the quadrivalent to the nonavalent vaccine from 2018. We also modelled the effects of the transition to primary HPV screening. We considered two scenarios for future screening recommendations regarding the cohorts who will be and who have been offered the nonavalent vaccine: either that HPV screening every 5 years continues, or that no screening would be offered to these women.FindingsWe estimate that, in Australia, the age-standardised annual incidence of cervical cancer will decrease to fewer than six new cases per 100 000 women by 2020 (range 2018–22), and to fewer than four new cases per 100 000 women by 2028 (2021–35). The precise year of attaining these rates is dependent on the population used for age-standardisation, HPV screening behaviour and test characteristics, the incremental effects of vaccination of men on herd immunity in women, and assumptions about the future frequency of benign hysterectomies. By 2066 (2054–77), the annual incidence of cervical cancer will decrease and remain at fewer than one case per 100 000 women if screening for HPV every 5 years continues for cohorts who have been offered the nonavalent vaccine, or fewer than three cases per 100 000 women if these cohorts are not screened. Cervical cancer mortality is estimated to decrease to less than an age-standardised annual rate of one death per 100 000 women by 2034 (2025–47), even if future screening is only offered to older cohorts that were not offered the nonavalent vaccine.InterpretationIf high-coverage vaccination and screening is maintained, at an elimination threshold of four new cases per 100 000 women annually, cervical cancer could be considered to be eliminated as a public health problem in Australia within the next 20 years. However, screening and vaccination initiatives would need to be maintained thereafter to maintain very low cervical cancer incidence and mortality rates.FundingNational Health and Medical Research Council (Australia)." @default.
• W2894633078 created "2018-10-12" @default.
• W2894633078 creator A5007964616 @default.
• W2894633078 creator A5046355615 @default.
• W2894633078 creator A5047316592 @default.
• W2894633078 creator A5048082417 @default.
• W2894633078 creator A5048686208 @default.
• W2894633078 creator A5058594959 @default.
• W2894633078 creator A5070990563 @default.
• W2894633078 creator A5084310936 @default.
• W2894633078 date "2019-01-01" @default.
• W2894633078 modified "2023-10-15" @default.
• W2894633078 title "The projected timeframe until cervical cancer elimination in Australia: a modelling study" @default.
• W2894633078 cites W1964927845 @default.
• W2894633078 cites W2004767921 @default.
• W2894633078 cites W2121732950 @default.
• W2894633078 cites W2126438085 @default.
• W2894633078 cites W2129827681 @default.
• W2894633078 cites W2141743074 @default.
• W2894633078 cites W2253806546 @default.
• W2894633078 cites W2314590113 @default.
• W2894633078 cites W2341021780 @default.
• W2894633078 cites W2472221349 @default.
• W2894633078 cites W2512321320 @default.
• W2894633078 cites W2528304237 @default.
• W2894633078 cites W2530408327 @default.
• W2894633078 cites W2559479498 @default.
• W2894633078 cites W2586260676 @default.
• W2894633078 cites W2595885523 @default.
• W2894633078 cites W2616528016 @default.
• W2894633078 cites W2738241331 @default.
• W2894633078 cites W2754735799 @default.
• W2894633078 cites W2780073244 @default.
• W2894633078 cites W2783482355 @default.
• W2894633078 cites W2788982635 @default.
• W2894633078 cites W2790356598 @default.
• W2894633078 cites W2793264364 @default.
• W2894633078 cites W575407695 @default.
• W2894633078 doi "https://doi.org/10.1016/s2468-2667(18)30183-x" @default.
• W2894633078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30291040" @default.
• W2894633078 hasPublicationYear "2019" @default.
• W2894633078 type Work @default.
• W2894633078 sameAs 2894633078 @default.
• W2894633078 citedByCount "244" @default.
• W2894633078 countsByYear W28946330782018 @default.
• W2894633078 countsByYear W28946330782019 @default.
• W2894633078 countsByYear W28946330782020 @default.
• W2894633078 countsByYear W28946330782021 @default.
• W2894633078 countsByYear W28946330782022 @default.
• W2894633078 countsByYear W28946330782023 @default.
• W2894633078 crossrefType "journal-article" @default.
• W2894633078 hasAuthorship W2894633078A5007964616 @default.
• W2894633078 hasAuthorship W2894633078A5046355615 @default.
• W2894633078 hasAuthorship W2894633078A5047316592 @default.
• W2894633078 hasAuthorship W2894633078A5048082417 @default.
• W2894633078 hasAuthorship W2894633078A5048686208 @default.
• W2894633078 hasAuthorship W2894633078A5058594959 @default.
• W2894633078 hasAuthorship W2894633078A5070990563 @default.
• W2894633078 hasAuthorship W2894633078A5084310936 @default.
• W2894633078 hasBestOaLocation W28946330781 @default.
• W2894633078 hasConcept C120665830 @default.
• W2894633078 hasConcept C121332964 @default.
• W2894633078 hasConcept C121608353 @default.
• W2894633078 hasConcept C126322002 @default.
• W2894633078 hasConcept C144024400 @default.
• W2894633078 hasConcept C149923435 @default.
• W2894633078 hasConcept C203014093 @default.
• W2894633078 hasConcept C22070199 @default.
• W2894633078 hasConcept C2777740455 @default.
• W2894633078 hasConcept C2778220009 @default.
• W2894633078 hasConcept C2780647465 @default.
• W2894633078 hasConcept C29456083 @default.
• W2894633078 hasConcept C2994532551 @default.
• W2894633078 hasConcept C61511704 @default.
• W2894633078 hasConcept C71924100 @default.
• W2894633078 hasConceptScore W2894633078C120665830 @default.
• W2894633078 hasConceptScore W2894633078C121332964 @default.
• W2894633078 hasConceptScore W2894633078C121608353 @default.
• W2894633078 hasConceptScore W2894633078C126322002 @default.
• W2894633078 hasConceptScore W2894633078C144024400 @default.
• W2894633078 hasConceptScore W2894633078C149923435 @default.
• W2894633078 hasConceptScore W2894633078C203014093 @default.
• W2894633078 hasConceptScore W2894633078C22070199 @default.
• W2894633078 hasConceptScore W2894633078C2777740455 @default.
• W2894633078 hasConceptScore W2894633078C2778220009 @default.
• W2894633078 hasConceptScore W2894633078C2780647465 @default.
• W2894633078 hasConceptScore W2894633078C29456083 @default.
• W2894633078 hasConceptScore W2894633078C2994532551 @default.
• W2894633078 hasConceptScore W2894633078C61511704 @default.
• W2894633078 hasConceptScore W2894633078C71924100 @default.
• W2894633078 hasFunder F4320334705 @default.
• W2894633078 hasIssue "1" @default.
• W2894633078 hasLocation W28946330781 @default.
• W2894633078 hasLocation W28946330782 @default.
• W2894633078 hasOpenAccess W2894633078 @default.
• W2894633078 hasPrimaryLocation W28946330781 @default.
• W2894633078 hasRelatedWork W2029893235 @default.
• W2894633078 hasRelatedWork W2057530095 @default.

• next